Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease

References

• ArjonaAAPoolerAMLeeRKWurtmanRJ2002Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigsBrain Research9511354012231467
   PubMed Web of Science ®Google Scholar
• BainsJBirksJSDeningTR2005Antidepressants for treating depression in dementiaCochrane Database of Systematic Reviews
   Web of Science ®Google Scholar
• BlennowKWallinAGottfriesCGLekmanAKarlssonISkoogISvennerholmL1992Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer’s diseaseNeurobiology of Aging131071131371850
   PubMed Web of Science ®Google Scholar
• BowenDMPalmerAMFrancisPTProcterAWLoweSLTerryRD1988“Classical” neurotransmitters in Alzheimer disease” Aging and the BrainRaven PressNew York115
   Google Scholar
• BraakHBraakE1991Neuropathological staging of Alzheimer-related changesActa Neuropathologica82239591759558
   PubMed Web of Science ®Google Scholar
• BraneGGottfriesCGBlennowKKarlssonILekmanAParnettiLSvennerholmLWallinA1989Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementiaAlzheimer Dis Assoc Disord3148562477044
   PubMedGoogle Scholar
• BremnerJDVermettenE2004Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorderAnnals of the New York Academy of Sciences1032154715677402
   PubMed Web of Science ®Google Scholar
• BurtDBZembarMJNiedereheG1995Depression and memory impairment: a meta-analysis of the association, its pattern, and specificityPsychological Bulletin1172853057724692
   PubMed Web of Science ®Google Scholar
• CalabreseFMolteniRMajPFCattaneoAGennarelliMRacagniGRivaMA2007Chronic Duloxetine Treatment Induces Specific Changes in the Expression of BDNF Transcripts and in the Subcellular Localization of the Neurotrophin ProteinNeuropsychopharmacology
   Web of Science ®Google Scholar
• CarliniVPGaydouRCSchiothHBde BarioglioSR2007Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intakeRegulatory Peptides140657317189653
   PubMedGoogle Scholar
• CasiniACacciaSScozzafavaASupuranCT2003Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and IIBioorganic & Medicinal Chemistry Letters132765812873510
   PubMed Web of Science ®Google Scholar
• ChenCPEastwoodSLHopeTMcDonaldBFrancisPTEsiriMM2000Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer’s disease prospectively assessed for behavioural changesNeuropathology and Applied Neurobiology26571211123724
   PubMed Web of Science ®Google Scholar
• ChenCPLHAdlerJTBowenDM1996Presynaptic serotonergic markers in community-acquired cases of Alzheimer’s disease: correlations with depression and medicationJournal of Neurochemistry66159288627315
   PubMed Web of Science ®Google Scholar
• CourtneyCFarrellDGrayRHillsRLynchLSellwoodEEdwardsSHardymanWRafteryJCromePLendonCShawHBenthamPAD2000Collaborative Group 2004. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trialLancet36321051515220031
   PubMed Web of Science ®Google Scholar
• CutlerNRHaxbyJKayADNarangPKLeskoLJCostaJLNinosMLinnoilaMPotterWZRenfrewJ1985Evaluation of zimeldine in Alzheimer’s disease. Cognitive and biochemical measuresArch Neurol4274482411246
   PubMed Web of Science ®Google Scholar
• DelisDCKramerJHKaplanEOberBA1987Harcourt Brace Jovanovich, IncSan Antonio
   Google Scholar
• DongHGoicoBMartinMCsernanskyCABertchumeACsernanskyJG2004Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stressNeuroscience127601915283960
   PubMed Web of Science ®Google Scholar
• DumontGJde VisserSJCohenAFvan GervenJMBiomarker Working Group of the German Association for Applied Human Pharmacology2005Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsBritish Journal of Clinical Pharmacology5949551015842547
   PubMed Web of Science ®Google Scholar
• EckertACotmanCWZerfassRHennericiMMullerWE1998Lymphocytes as cell model to study apoptosis in Alzheimer’s disease: vulnerability to programmed cell death appears to be alteredJournal of Neural Transmission Supplement54259679850934
   PubMedGoogle Scholar
• EgashiraNMatsumotoYMishimaKIwasakiKFujiokaMMatsushitaMShoyamaYNishimuraRFujiwaraM2006Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilizationPharmacology, Biochemistry and Behavior831617
   Web of Science ®Google Scholar
• EtcheberrigarayRBhagavanS1999Ionic and signal transduction alterations in Alzheimer’s disease: relevance of studies on peripheral cellsMolecular Neurobiology209310910966116
   PubMed Web of Science ®Google Scholar
• FinkelSIMintzerJEDyskenMKrishnanKRBurtTMcRaeT2004A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer’s disease in outpatients treated with donepezilInternational journal of geriatric psychiatry1991814716694
   PubMed Web of Science ®Google Scholar
• GobbiGBlierP2005Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugsPeptides2613839316042978
   PubMed Web of Science ®Google Scholar
• GriffinWSShengJGMrakRE1998Senescence-accelerated overexpression of S100beta in brain of SAMP6 miceNeurobiology of Aging197169562506
   PubMed Web of Science ®Google Scholar
• Hajos-KorcsokEMcTavishSFSharpT2000Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetineEuropean Journal of Pharmacology407101711050296
   PubMed Web of Science ®Google Scholar
• HaringJHHaganAOlsonJRodgersB1993Hippocampal serotonin levels influence the expression of S100 beta detected by immunocytochemistryBrain Research631119238298984
   PubMed Web of Science ®Google Scholar
• HuangSCTsaiSJChangJC2004Fluoxetine-induced memory impairment in four family membersInternational Journal of Psychiatry in Medicine3419720015387402
   PubMed Web of Science ®Google Scholar
• JackCRJShiungMMWeigandSDO’BrienPCGunterJLBoeveBFKnopmanDSSmithGEIvnikRJTangalosEGPetersenRC2005Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCINeurology6512273116247049
   PubMed Web of Science ®Google Scholar
• JossJDBurtonRMKellerCA2003Memory loss in a patient treated with fluoxetineThe Annals of Pharmacotherapy371800314632599
   PubMed Web of Science ®Google Scholar
• JossanSSAdemAWinbladBOrelandL1992Characterisation of dopamine and serotonin uptake inhibitory effects of tetrahydroaminoacridine in rat brainPharmacol Toxicol7121351438045
   PubMedGoogle Scholar
• KhaliqSHaiderSAhmedSPPerveenTHaleemDJ2006Relationship of brain tryptophan and serotonin in improving cognitive performance in ratsPakistan Journal of Pharmaceutical Sciences1911516632446
   PubMedGoogle Scholar
• KogenHTodaNTagoKMarumotoSTakamiKOriMYamadaNKoyamaKNarutoSAbeKYamazakiRHaraTAoyagiAAbeYKanekoT2002Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer’s diseaseOrganic Letters433596212323018
   PubMed Web of Science ®Google Scholar
• LanctotKLHerrmannNYauKKKhanLRLiuBALouLouMMEinarsonTR2003Efficacy and safety of cholinesterase inhibitors in Alzheimer’s disease: a meta-analysisCanadian Medical Association Journal1695576412975222
   PubMed Web of Science ®Google Scholar
• LotrichFEPollockBG2005Candidate genes for antidepressant response to selective serotonin reuptate inhibitorsNeuropsychiatr Dis Treat1173518568127
   PubMedGoogle Scholar
• LyketsosCGDelCampoLSteinbergMMilesQSteeleCDMunroCBakerASSheppardJMFrangakisCBrandtJRabinsPV2003Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADSArch Gen Psychiatry607374612860778
   PubMed Web of Science ®Google Scholar
• MacPhersonADinkelKSapolskyR2005Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal culturesExperimental Neurology1943768316022865
   PubMed Web of Science ®Google Scholar
• MattsonMPMaudsleySMartinB2004BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegerative disordersTrends in Neuroscience2758994
   PubMed Web of Science ®Google Scholar
• MeeterMTalaminiLSchmittJARiedelWJ2006Effects of 5-HT on memory and the hippocampus: model and dataNeuropsychopharmacology317122016132065
   PubMed Web of Science ®Google Scholar
• MenesesA1998Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memoryReviews in the Neurosciences9275899886142
   PubMed Web of Science ®Google Scholar
• MenesesA2001Effects of the 5-HT(6) receptor antagonist Ro 04-6790 on learning consolidationBehav Brain Res1181071011163639
   PubMed Web of Science ®Google Scholar
• MenesesA2003A pharmacological analysis of an associative learning task: 5-HT1 to 5-HT7 receptor subtypes function on a Pavlovian/instrumental autoshaped memoryLearning and Memory103637214557609
   PubMed Web of Science ®Google Scholar
• MenesesAHongE1995Effect of fluoxetine on learning and memory involves multiple 5-HT systemsPharmacol Biochem Behav5234168577800
   PubMed Web of Science ®Google Scholar
• MenesesATerronJA2001Role of 5-HT(1A) and 5-HT(7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidationBehav Brain Res12121811275281
   PubMed Web of Science ®Google Scholar
• MenesesATerronJAHongE1997Effects of the 5-HT receptor antagonists GR127935 (5-HT1B/1D) and MDL100907 (5-HT2A) in the consolidation of learningBehav Brain Res89217239475628
   PubMed Web of Science ®Google Scholar
• MitchellESNeumaierJF20055-HT6 receptors: a novel target for cognitive enhancementPharmacology and Therapeutics1083203316005519
   PubMed Web of Science ®Google Scholar
• Mnie-FilaliOEl MansariMEspanaASanchezCHaddjeriN2006Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticityNeuroscience Letters39523716330146
   PubMed Web of Science ®Google Scholar
• MorseLJPaytonSMCunyGDRogersJT2004FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor proteinJournal of Molecular Neuroscience241293615314261
   PubMed Web of Science ®Google Scholar
• National Institute on Aging, aRIWGoDCftNAoAsD1997Consensus recommendations for the postmortem diagnosis of Alzheimer’s diseaseNeurobiology of Aging18S129330978
   PubMed Web of Science ®Google Scholar
• NazaraliAJReynoldsGP1992Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer’s disease: a post-mortem studyCellular and Molecular Neurobiology1258171283363
   PubMed Web of Science ®Google Scholar
• NibuyaMNestlerEJDumanRS1996Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampusJournal of Neuroscience162365728601816
   PubMed Web of Science ®Google Scholar
• NythALGottfriesCG1990The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre studyBr J Psychiatry1578949011705151
   PubMed Web of Science ®Google Scholar
• OhashiSMatsumotoMOtaniHMoriKTogashiHUenoKKakuAYoshiokaM2002Changes in synaptic plasticity in the rat hippocampomedial prefrontal cortex pathway induced by repeated treatments with fluvoxamineBrain Research949131812213308
   PubMed Web of Science ®Google Scholar
• PageMEAbercrombieED1997An analysis of the effects of acute and chronic fluoxetine on extracellular norepinephrine in the rat hippocampus during stressNeuropsychopharmacology16419259165497
   PubMed Web of Science ®Google Scholar
• PalotasAKalmanJPalotasMJuhaszAJankaZPenkeB2002Beta-amyloid induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control onesBrain Research Bulletin58203512127018
   PubMed Web of Science ®Google Scholar
• PalotasAPuskasLGKitajkaKPalotasMMolnarJPakaskiMJankaZPenkeBKalmanJ2004The effect of citalopram on gene expression profile of Alzheimer lymphocytesNeurochemical Research2915637015260135
   PubMed Web of Science ®Google Scholar
• PaytonSCahillCMRandallJDGullansSRRogersJT2003Drug discovery targeted to the Alzheimer’s APP mRNA 5’-untranslated region: the action of paroxetine and dimercaptopropanolJournal of Molecular Neuroscience202677514501007
   PubMed Web of Science ®Google Scholar
• PollockBGMulsantBHRosenJSweetRMazumdarSBharuchaAMarinRJacobNJHuberKAKastangoKBChewML2002Comparison of Citalopram, Perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patientsAmerican Journal of Psychiatry1594606511870012
   PubMed Web of Science ®Google Scholar
• PollockBGRosenJMulsantBH1999Antipsychotics and selective serotonin reuptake inhibitors for the treatment of behavioral disturbances in dementia of the Alzheimer type: a review of clinical dataConsultant Pharmacist11125158
   Google Scholar
• ProcterAWFrancisPTStratmannGCBowenDM1992Serotonergic pathology is not widespread in Alzheimer’s patients without prominent aggressive symptomsNeurochemical Research17917221357564
   PubMed Web of Science ®Google Scholar
• ReevesRYaoJMRCBuckSZhangXYarowskyPGearhartJDHiltDC1994Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic miceProceedings of the National Academy of Science U S A91535963
   PubMed Web of Science ®Google Scholar
• ReinikainenKJSoininenHRiekkinenPJ1988A post-mortem study of noradrenergic, serotonergic and gabaergic neurons in Alzheimer’s diseaseJournal of the Neurological Sciences84101162452858
   PubMed Web of Science ®Google Scholar
• SapolskyR2003Taming stressScientific American289869512951832
   PubMed Web of Science ®Google Scholar
• SchechterLESmithDLRosenzweig-LipsonSSukoffSJDawsonLAMarquisKJonesDPieslaMAndreeTNawoschikSHarderJAWomackMDBuccafuscoJTerryAVHoebelBRadaPKellyMAbou-GharbiaMBarrettJEChildersWJ2005Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing propertiesPharmacol Exp Ther314127489
   PubMed Web of Science ®Google Scholar
• SchiapparelliLDel RioJFrechillaD2005Serotonin 5-HT receptor blockade enhances Ca(2+)/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formationJournal of Nerochemistry9488495
   Web of Science ®Google Scholar
• ShelineYISanghaviMMintunMAGadoMH1999Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depressionJournal of Neuroscience1950344310366636
   PubMed Web of Science ®Google Scholar
• ShengJGMrakRERovnaghiCRKozlowskaEVan EldikLJGriffinWS1996Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer’s diseaseNeurobiology of Aging17359638725896
   PubMed Web of Science ®Google Scholar
• SjogrenMMinthonLPassantUBlennowKWallinA1998Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s diseaseNeurobiology of Aging19379849880039
   PubMed Web of Science ®Google Scholar
• SmithJELakoskiJM1998Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampusSynapse30318289776135
   PubMed Web of Science ®Google Scholar
• StewartCAReidIC2000Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticityPsychopharmacology1482172310755734
   PubMed Web of Science ®Google Scholar
• SunM-KAlkonDL2001Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in ratsThe Journal of Pharmacology and Experimental Therapeutics2979616711356917
   PubMed Web of Science ®Google Scholar
• ThomasDNNuttDJHolmanRB1998Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortexJournal of Psychopharmacology123667010065910
   PubMed Web of Science ®Google Scholar
• ThomasiusRZapletalovaPPetersenKBuchertRAndresenBWartbergLNebelingBSchmoldtA2006Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspectiveJournal of Psychopharmacology202112516510479
   PubMed Web of Science ®Google Scholar
• TohgiHAbeTTakahashiSSahekiMKimuraM1995Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitorJournal of Neural Transmission. Parkinsons Disease and Dementia Section912131
   Google Scholar
• UedaSSakakibaraSYoshimotoK2005Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learningNeuroscience13539540216125851
   PubMed Web of Science ®Google Scholar
• van der VeenFMEversEAvan DeursenJADeutzNEBackesWHSchmittJA2006Acute tryptophan depletion reduces activation in the right hippocampus during encoding in an episodic memory taskNeuroimage3111889616513369
   PubMed Web of Science ®Google Scholar
• ViziESZsillaGCaronMGKissJP2004Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitorsJournal of Neuroscience2478889415356201
   PubMed Web of Science ®Google Scholar
• WechslerD1987Harcourt, Brace, Jovanovich, IncSan Antonio
   Google Scholar